Overall rank by patents
#2,513
Across all tracked assignees
USPTO PatentsView assignee record - 155 granted patents across 29 technology areas, active 2015–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: C12P (FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE).
The verdict
Genomatica holds 155 US patents across 29 technology areas, rank #2,513 of 50,000 tracked assignees.
Genomatica, Inc. has been granted 155 US utility patents between 2015 and 2025, placing Genomatica, Inc. at rank #2,513 across all assignees tracked by PlainPatent. This portfolio spans 29 distinct Cooperative Patent Classification (CPC) subclasses, averaging 17.0 claims per patent with primary concentration in C12P (FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE). As a US Corporation, Genomatica, Inc. is one of the more focused assignees in the PatentsView dataset. By volume, Genomatica sits between Access Business Group International Llc (155 patents, rank #2,509) and ONO Pharmaceutical Co., Ltd. (155 patents, rank #2,517) - the closest US assignees by grant volume. The composite Innovation Score of 51.5/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Between 2020 and 2025 the company received 89 grants, compared with 66 in the 2015–2019 window, a +35% shift in five-year velocity. Steady filing volume suggests sustained innovation without dramatic pivots. The US Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. Genomatica, Inc.'s 17.0 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while a multi-domain presence across 29 subclasses balances depth with breadth. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Genomatica, Inc. against peers pursuing similar technology classes.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
Access Business Group International LLC
155 patents
BNSF Railway Company
155 patents
Berkshire Grey Operating Company, Inc.
155 patents
Emerson Process Management Regulator Technologies, Inc.
155 patents
IDEMIA IDENTITY & SECURITY FRANCE
155 patents
Newport Fab, LLC
155 patents
OCE-TECHNOLOGIES B.V.
155 patents
ONO PHARMACEUTICAL CO., LTD.
155 patents
Genomatica, Inc.
155 patents
What this shows Genomatica holds 155 patents at rank #2,513, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #2,513 in granted patent volume.
Other assignees with the most granted patents in Genomatica's primary technology class.
Genomatica's Innovation Score vs. every tracked assignee
Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)
51 Top 11% higher than 89% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 15 | 9.7% |
| 2016 | 10 | 6.5% |
| 2017 | 10 | 6.5% |
| 2018 | 17 | 11.0% |
| 2019 | 14 | 9.0% |
| 2020 | 20 | 12.9% |
| 2021 | 20 | 12.9% |
| 2022 | 17 | 11.0% |
| 2023 | 13 | 8.4% |
| 2024 | 9 | 5.8% |
| 2025 | 10 | 6.5% |
Top 15 of 29 technology areas
Overall rank by patents
#2,513
Across all tracked assignees
51.5 out of 100
How to use this portfolio
Genomatica's 155 grants land it in the top 11% by Innovation Score, but volume alone doesn't tell you where the strength sits.
Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.